Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis

QR Code

Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis

Noll Campbell1, Amir Ayub2, Malaz A Boustani2, Chris Fox3, Martin Farlow4, Ian Maidment3, Robert Howard51Wishard Health Services, Indianapolis, Indiana; 2Indiana University Center for Aging Research, Regenstrief Institute, Inc., Indianapolis, Indiana; 3University of Kent, Kent, United Kingdom; 4Indi...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Noll Campbell, Amir Ayub, Malaz A Boustani, Chris Fox, Martin Farlow, et al
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2008
Sujets:	Alzheimer's disease dementia cholinesterase inhibitors behavioral and psychological symptoms Geriatrics RC952-954.6
Accès en ligne:	https://doaj.org/article/5cd558d253c44852b6471ca244f81b4c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
par: Ben Seltzer
Publié: (2009)

A longitudinal study of risk factors for community-based home help services in Alzheimer’s disease: the influence of cholinesterase inhibitor therapy
par: Wattmo C, et autres
Publié: (2013)

Real-world evaluation of compliance and preference in Alzheimer’s disease treatment
par: Pai MC, et autres
Publié: (2015)

Antagonism of morphine-induced central respiratory depression by donepezil in the anesthetized rabbit
par: TSUJITA,MIKI, et autres
Publié: (2007)

Discovery of Guanidine Derivatives from <i>Buthus martensii</i> Karsch with Metal-Binding and Cholinesterase Inhibition Properties
par: Yu-Ming Liu, et autres
Publié: (2021)

Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease
par: Yoshiyuki Kagawa, et autres
Publié: (2021)

Patient characteristics associated with screening positive for Alzheimer’s disease and related dementia
par: Fowler NR, et autres
Publié: (2018)

New possibility of traditional Chinese and Japanese medicine as treatment for behavioral and psychiatric symptoms in dementia
par: Kung FC, et autres
Publié: (2012)

Editorial: Alzheimer's Disease From a Psychiatric Perspective: Towards New Therapeutic Guidelines?
par: Marc Fakhoury, et autres
Publié: (2021)

Donepezil reverses buprenorphine-induced central respiratory depression in anesthetized rabbits
par: SAKURABA,SHIGEKI, et autres
Publié: (2009)

Relation of Breast Cancer and Malathion Aerial Spraying in Arica, Chile
par: Cabello,Gertrudis, et autres
Publié: (2013)

Long-term effect of galantamine on cognitive function in patients with Alzheimer’s disease versus a simulated disease trajectory: an observational study in the clinical setting
par: Nakagawa R, et autres
Publié: (2017)

Late onset Alzheimer’s disease in older people
par: Ahmet Turan Isik
Publié: (2010)

Plasma cholinesterase is associated with Chinese adolescent overweight or obesity and metabolic syndrome prediction
par: Han Y, et autres
Publié: (2019)

Enfermedad de Alzheimer: Actualización en terapia farmacológica
par: Fuentes G,Patricio, et autres
Publié: (2005)

Management of psychosis in patients with Alzheimer’s disease: focus on aripiprazole
par: Subramanian Madhusoodanan, et autres
Publié: (2008)

Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions
par: Millán-Calenti JC, et autres
Publié: (2016)

Red neural por defecto y enfermedad de Alzheimer
par: Vergara E,Fernando, et autres
Publié: (2013)

Phenolic composition, antioxidant activity, anticholinesterase potential and modulatory effects of aqueous extracts of some seaweeds on β-amyloid aggregation and disaggregation
par: Tosin A. Olasehinde, et autres
Publié: (2019)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
par: Stuart J Thomas, et autres
Publié: (2009)

Circulating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study
par: Adams CD
Publié: (2020)

Comunicación diagnóstica en enfermedad de Alzheimer: Reflexión y propuesta
par: Fuentes R,Paola, et autres
Publié: (2012)

Apolipoprotein E e4 allele is associated with extrapyramidal symptoms in Alzheimer’s disease
par: Chang YP, et autres
Publié: (2019)

Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
par: Mannu P, et autres
Publié: (2011)

The Effect of Type 2 Diabetes Mellitus on Neuropsychological Symptoms in Chinese Early Alzheimer’s Disease Population
par: Shi Q, et autres
Publié: (2020)

Practical clinical tool to monitor dementia symptoms: the HABC-Monitor
par: Monahan PO, et autres
Publié: (2012)

Effectiveness and Safety of Aromatherapy in Managing Behavioral and Psychological Symptoms of Dementia: A Mixed-Methods Systematic Review
par: Becky Siu Yin Li, et autres
Publié: (2021)

Alzheimer's care today

PSEN1 L226F mutation in a patient with early-onset Alzheimer’s disease in Korea
par: Bagyinszky E, et autres
Publié: (2016)

Abnormal functional connectivity of the posterior cingulate cortex is associated with depressive symptoms in patients with Alzheimer’s disease
par: Zhang J, et autres
Publié: (2017)

Different durations of cognitive stimulation therapy for Alzheimer’s disease: a systematic review and meta-analysis
par: Chen J, et autres
Publié: (2019)

UPLC-MS/MS Profiling, Antioxidant, α-Glucosidase Inhibitory, Cholinesterase Inhibitory, and Cardiovascular Protection Potentials of Jialing 20 (<i>Morus multicaulis</i> Perr.) Mulberry Branch Extract
par: Wei Xiang, et autres
Publié: (2021)

Síntomas psicológicos y conductuales asociados a demencias: actualización terapéutica
par: Slachevsky Ch,Andrea, et autres
Publié: (2005)

Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy
par: Campbell NL, et autres
Publié: (2015)

Salivary Biomarkers in Alzheimer´s Disease
par: Santos,Gustavo A. A, et autres
Publié: (2020)

Validación de un test de tamizaje para el diagnóstico de demencia asociada a edad, en Chile
par: Quiroga L,Pilar, et autres
Publié: (2004)

Precision Medicine of Sodium Benzoate for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)
par: Lin CH, et autres
Publié: (2020)

Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
par: Longfei Jia, et autres
Publié: (2021)

Public–private partnerships improve health outcomes in individuals with early stage Alzheimer’s disease
par: Galvin JE, et autres
Publié: (2014)

Evaluation of a computer-assisted errorless learning-based memory training program for patients with early Alzheimer’s disease in Hong Kong: a pilot study
par: Lee GY, et autres
Publié: (2013)